Cibc World Markets Corp Aquestive Therapeutics, Inc. Transaction History
Cibc World Markets Corp
- $14.8 Billion
- Q2 2025
A detailed history of Cibc World Markets Corp transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Cibc World Markets Corp holds 10,601 shares of AQST stock, worth $72,298. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,601
Previous 16,479
35.67%
Holding current value
$72,298
Previous $47,000
25.53%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding AQST
# of Institutions
132Shares Held
49.3MCall Options Held
64.2KPut Options Held
204K-
Bratton Capital Management, L.P. Fort Worth, TX9.81MShares$66.9 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.45MShares$37.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.33MShares$29.5 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.98MShares$20.3 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY2.19MShares$14.9 Million0.32% of portfolio
About Aquestive Therapeutics, Inc.
- Ticker AQST
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,350,700
- Market Cap $364M
- Description
- Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...